Dudediligence.

Innoviva, Inc

INVANASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Revenue
$440.0Mlast 12 months
Net income
$357.2Mlast 12 months
Operating cash flow
$183.6Mlast 12 months
Cash and equivalents
$570.4Mat the last balance sheet
Total debt
$258.5Mat the last balance sheet
Shares outstanding
72.6M shareson issue
Every year and quarter →